Company Overview and News

 
BRIEF-Internet Of Things Received TSX Venture Approval For Joint Venture Agreement With New Hope Group

2018-04-13 reuters
* INTERNET OF THINGS INC. RECEIVED TSX VENTURE APPROVAL FOR JOINT VENTURE AGREEMENT WITH NEW HOPE GROUP Source text for Eikon: Further company coverage:
Upvote Downvote

1
The R.I.P. Portfolio: Q1 2018 Update

2018-04-03 seekingalpha
This real-money portfolio was first introduced to the Seeking Alpha community in December 2015 and it outperformed its benchmark in each of the last two years.
Upvote Downvote

 
Everyone is a Closet Technician

2018-03-29 thereformedbroker
Everyone is a closet technician. Everyone. And in a panic or a market correction, this truism is even more, um, truistic.
Upvote Downvote

 
AT&T: It Will Be Different This Time Around

2018-02-21 seekingalpha
AT&T has underperformed the broader market since early 2015, but it will be different this time around.
Upvote Downvote

1
Want To Have The Growth Of T-Mobile And The Dividend Of AT&T: Look At Deutsche Telekom

2018-02-13 seekingalpha
Telecom Giants like AT&T and Verizon are deeply challenged by aggressive competition coming from T-Mobile US or Sprint.
Upvote Downvote

1
Meet Borqs CEO Pat Chan As He Talks About Internet Of Things, Android Software And The Inception Of Borqs

2018-02-10 valuewalk
When Executive Casts interviewed $BRQS CEO Pat Chan, we wanted to give him the opportunity to fully introduce himself to investors, a common and ongoing theme that the platform likes to showcase.  Executive Casts serves to help investors learn about smaller publicly traded companies, and doubles as a learning tool integral to the process of getting to intimately know key company executives. Borqs is a global leader in software and products for Internet of Things providing customizable, differentiated and scalable Android-based smart connected devices and cloud service solutions.
Upvote Downvote

 
Aspen Technology's (AZPN) CEO Antonio Pietri on Q2 2018 Results - Earnings Call Transcript

2018-01-25 seekingalpha
Good afternoon. My name is Rose, and I will be your conference operator for today. At this time, I would like to welcome everyone to the Second Quarter of Fiscal 2018 Earnings Call. All lines have been placed on mute, to prevent any background noise. After the speakers remarks, there will be a question-and-answer session. [Operator Instructions]
Upvote Downvote

2
The R.I.P. Portfolio: Q4 2017 Update

2018-01-03 seekingalpha
This real-money portfolio was first introduced to the Seeking Alpha community in December 2015, and it has outperformed the S&P 500 since that point in time.
Upvote Downvote

 
The race to own the autonomous super highway: Digging deeper into Broadcom’s offer to buy Qualcomm | Robohub

2017-11-14 robohub.org
Research & Innovation Business & Finance Health & Medicine Politics, Law & Society Arts & Entertainment Education & DIY Events Military & Defense Exploration & Mining Mapping & Surveillance Enviro. & Agriculture Aerial Automotive Industrial Automation Consumer & Household Space
Upvote Downvote

 
Apple: You've Got This All Wrong

2017-10-23 seekingalpha
The incredible growth opportunity in IoT has me looking at connected devices as the next big technology focus for the tech behemoth.
Upvote Downvote

1
The R.I.P. Portfolio: Q3 2017 Update

2017-10-02 seekingalpha
This real-money portfolio was first introduced in December 2015 to the Seeking Alpha community, and the portfolio has outperformed the S&P 500 since that point in time.
Upvote Downvote

 
Verizon's Q2 2017 Earnings: Impressive Financial Results But Concerns Remain

2017-07-28 seekingalpha
The Q2 2017 results were well-received by the market, but investors should closely monitor the company's FCF and growing debt balance in the quarters ahead.
Upvote Downvote

1
The Internet Of Things: Now There's A Growth Story

2017-07-23 seekingalpha
Depending on who you ask, you might get a different definition of the Internet of Things (IOT). Some might even call it the Internet of Everything or the Internet of Everywhere. Whatever name might stick in the future, one thing is certain – it is going to change the way we live our lives.
Upvote Downvote

 
Thales Alenia Space to provide Argos Neo instrument for French space agency nano-satellite demonstrator, Angels

2017-05-19 asdnews
You are here: ASDNews Home > Thales Alenia Space to provide Argos Neo instrument for French space agency nano-satellite demonstrator, Angels
Upvote Downvote

 
The Internet Of Things = The Internet Of NAND - Good News For Micron

2017-05-18 seekingalpha
"The 'Internet of Things' means sensors connected to the Internet and behaving in an Internet-like way by making open, ad hoc connections, sharing data freely and allowing unexpected applications, so computers can understand the world around them and become humanity's nervous system." Kevin Ashton (inventor of the term)
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...